Main Catalog

AMCP Web Site

Main Catalog

Found 74

Sort By

Member Free

Non-Member Free

Perspectives on Providing Value in Oncology: A Panel Discussion

Contact Hours: 1 - Perceptions of value in oncology care vary among stakeholders.

Oncology

Member

Non-Member

Keeping Up with Rare Disease Therapies: Pipeline to Management Solutions Track

Contact Hours: 1 - Over the last several years, payers have increased their focus on the management of rare diseases.

Drug Pipeline Rare Diseases

Member

Non-Member

Value-Based Payment Models: Opportunities to Integrate Pharmacists from a Variety of Practice Settings

Contact Hours: 1 - Shared savings plans can mitigate health care costs, but how do we establish the relationships required for their success?

Value-Based Contracting

Member

Non-Member

The Role of Health Disparities and Social Determinants of Health in Promoting Health and Health Equity

Contact Hours: 1 - Health care disparities are often viewed through the lens of race/ethnicity and socioeconomic status.

Health Disparities Social Determinants

Member

Non-Member

Keeping Up with State Legislators: Legislative Updates and Outlook

Contact Hours: 1 - The COVID-19 pandemic had a significant impact on state legislation and regulation.

Legislation

Member Free

Non-Member Free

Navigating Changes in Clostridioides difficile Prevention and Treatment

Contact Hours: 1. 5 - Clostridioides difficile (C. diff, previously known as Clostridium difficile) infections are a major health care concern.

C. Diff

Member

Non-Member

White and Brown Bagging: Emerging Practice, Legislative and Board of Pharmacy Trends

Contact Hours: 1 - The growth of specialty pharmacy has resulted in an increase of white bagging and brown bagging.

Brown Bagging

Member

Non-Member

Impact of Prescription Drug Reference Pricing on Drug Spend and Utilization

Contact Hours: 1 - Prescription drug reference pricing is an emerging pharmacy benefit management tool that aligns plan reimbursement to clinical value.

Drug Pricing

Member

Non-Member

Overcoming Barriers to Biosimilar Adoption through Coordinated Efforts

Contact Hours: 1 - Biosimilars are considered a fundamental pillar to containing drug spend in today’s health care systems.

Biosimilars

Member

Non-Member

Population Management: Zooming in on Rare Diseases with ICER Reports

Contact Hours: 1 - An estimated 10% of the population has a rare disease, according to the National Organization of Rare Disorders (NORD), which lists over 1,200 rare diseases.

ICER

Main Catalog

Error